News

In The News ADVI’s Vice President, Lindsay Bealor Greenleaf, explained to Modern Healthcare about the implications of CMS’ new proposed rule for Medicaid
In The News ADVI Vice President, Dr. Michael Kolodziej, recently shared his thoughts on how commercial insurers and hospitals are being impacted by the Covid-19 pandemic with The Cancer Letter
In The News ADVI’s Director, Becca Davison, connected with Fox Business to discuss what she’d like to see from lawmakers when it comes to health policy
In The News ADVI’s Lindsay Bealor Greenleaf talks to Politico about the new Medicaid proposed rule
In The News ADVI’s Lindsay Bealor Greenleaf sat down with the Daily Caller to discuss some of the problems that this proposal would have posed for patients
In The News “Insulins are typically heavily rebated products, and Part D beneficiaries’ out-of-pocket costs are based on a pre-rebated list price,” ADVI VP Lindsay Bealor Greenleaf explained to BioWorld about the costs of insulin
In The News Following the White House’s announcement on insulin cost caps in Medicare, ADVI’s Lindsay Bealor Greenleaf sat down with the American Journal of Managed Care to share her thoughts
In The News ADVI’s Dr. Michael Kolodziej and Texas Oncology’s Dr. Debra Patt share their thoughts on how COVID-19 is impacting the oncology space through the lens’ of patients, providers, payers, and other areas in The Cancer Letter
In The News ADVI’s Lindsay Bealor Greenleaf spoke with the American Journal of Managed Care to Discuss the State of Medicare Advantage and Impacts from the Covid-19 Outbreak